Article
Innovation Incentives in the Pharmaceutical Sector: Re-thinking Competition and Public Policy?
2021-05-14
Abstract excerpt
The incentives to innovate of pharmaceutical companies and how competition affects these incentives has been topical in recent years: for the general public, as evidenced by a patent race at an unprecedented pace during the ongoing COVID-19 pandemic; and more specifically for competition authorities, as demonstrated for example by the role innovation played in the assessment of the Bayer/Monsanto (2018), Dow/DuPon...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1cd2f0f4-6db6-5cb5-84b7-e881a92d8356
- DOI
- 10.2139/ssrn.3845568